Last Updated: October 3, 2025
Analyzing Management
Leadership of public companies plays a crucial role for hedge funds and asset managers during both initial due diligence and ongoing risk assessments. ManagementTrack offers a systematic approach that eliminates distractions—highlighting distinct strengths and weaknesses, identifying warning signs and positive indicators, and establishing a clear connection between CEO actions and investment performance.
CEO Chapman’s billing history may jeopardize payer relations and clinical progress.
Analysis of Natera CEO Steve Chapman
Despite his proven ability to drive aggressive sales growth, a history of improper billing and transparency issues may leave Steve Chapman poorly positioned to manage critical payer relationships and de-risk clinical programs.
Management evaluated Steve Chapman’s track record and skillset against the following key factors for NTRA:
- De-risking the ECD program with the pivotal PROCEED trial data.
- Securing payer coverage for new indications to unlock revenue.
- Proving operating leverage to achieve sustained profitability.
- Sustaining Signatera’s record growth via sales force expansion.
Steve Chapman’s Track Record & Key Open Questions to Research
ManagementTrack provides track record analysis, career playbooks, strengths, and weaknesses for every CEO. It allows investors to dig deeper to uncover hard to find data to answer the most pressing questions.
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ for more information.
Question #1
When Chapman sets aggressive commercial targets, does he also establish and enforce the necessary compliance guardrails to prevent a “growth-at-all-costs” culture, or does the pressure to execute inevitably lead his teams to operate in gray areas?
Question #2
In situations where clinical data is ambiguous or less favorable than hoped, does Chapman prioritize transparently communicating the scientific limitations, or does he push his teams to find the most aggressive commercial narrative the data can support?
Question #3
As Chapman pivots Natera towards profitability, has he demonstrated the operational discipline to enforce margin control, or does his ingrained focus on top-line growth lead him to revert to his aggressive spending playbook when facing competitive pressure?
Why Do Investors Use ManagementTrack?
How does ManagementTrack evaluate Steve Chapman at NTRA?
ManagementTrack assesses an executive’s track record, core competencies, and potential weaknesses through its proprietary career analysis and interviews with former colleagues. This profile is then measured against NTRA’s most critical challenges: de-risking the pivotal ECD program, securing broad payer coverage, achieving sustained profitability, and sustaining Signatera’s rapid growth.
What other tools does ManagementTrack utilize to link executive leadership to a company’s future results?
ManagementTrack utilizes proprietary models to identify and quantify executive evasion during earnings call Q&A, flagging behavior that deviates from the norm. The platform also scrutinizes all insider transactions to isolate outlier trades that signal potential future stock over- or underperformance. These signals, when integrated with the predictive ManagementTrack Rating—a 1-10 score for each executive—provide investors with a distinct, actionable perspective on how leadership will likely influence company performance.
Which companies does ManagementTrack cover?
ManagementTrack provides real-time analysis on the c-suite executives of all publicly traded companies.
How to Learn More
Reach out to sales@paragonintel.com or visit https://paragonintel.com/access-now/ to see our deep dive analysis on any executive.
Author
Author: Colby Howard is the co-founder and President of Paragon Intel. Paragon Intel’s ManagementTrack is the premier executive analysis platform for hedge funds, asset managers, corporations, boards, and recruiters. Our proprietary data, built over a decade of analysis, allows us to analyze each public company executive to understand their fit and ability to execute at their company. We leverage our proprietary data – key quantitative research on an executive’s career plus interviews with their former colleagues – with public documents, including SEC filings (10-K, 10-Q), investor presentations, press releases, and earnings call transcripts. to build a holistic, evidence-based view of an executive’s capabilities and playbook.
Sources
- Verified Career History by ManagementTrack for Steve Chapman
- Analysis of Capital Allocation, Performance, and Fundamentals across career by ManagementTrack
- Natera, Inc. 10Q
- Natera, Inc. 10K
- Natera, Inc. Earnings Calls
- Natera, Inc. Press Releases
Relevant Links
- For more information on ManagementTrack’s Data visit: https://paragonintel.com/management-track-data/
- For more information on ManagementTrack’s Interview & Analysis visit: https://paragonintel.com/management-track-reports/
- For more information on ManagementTrack’s Interview library visit: https://paragonintel.com/management-track-report-library/
- For more information on ManagementTrack’s Evasion Analysis visit: https://paragonintel.com/earnings-call-evasion/
- For more information on how ManagementTrack helps hedge funds and asset managers visit: https://paragonintel.com/
